Cyclacel Pharmaceuticals, Inc.
(NASDAQ : CYCC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. 0.71%245.541.3%$801.51m
IMMUImmunomedics, Inc. 0.11%85.4611.0%$698.00m
MRNAModerna, Inc. 0.74%69.990.0%$671.48m
NVAXNovavax, Inc. -4.20%108.7996.5%$602.59m
ILMNIllumina, Inc. 0.10%300.183.5%$583.35m
GILDGilead Sciences, Inc. 0.73%62.711.0%$578.35m
REGNRegeneron Pharmaceuticals, Inc. -1.61%564.832.7%$436.26m
BIIBBiogen, Inc. 3.87%283.861.6%$347.94m
VRTXVertex Pharmaceuticals, Inc. -0.79%266.071.9%$338.17m
ALXNAlexion Pharmaceuticals, Inc. -0.71%113.622.0%$283.20m
EXASEXACT Sciences Corp. 1.61%99.2720.7%$261.42m
SRNESorrento Therapeutics, Inc. 5.34%10.151.5%$253.74m
SGENSeattle Genetics, Inc. 2.16%188.956.0%$216.73m
VXRTVaxart, Inc. -6.89%6.890.0%$199.14m
MNTAMomenta Pharmaceuticals, Inc. 0.09%52.453.0%$193.77m

Company Profile

Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.